Brief: Aytu Biopharma Reports Positive Preclinical Data For Healight Delivery Technology

Aytu Biopharma

25/04/2022 13:15

April 25 (Reuters) - Aytu Biopharma Inc  AYTU.O :
    * AYTU BIOPHARMA ANNOUNCES POSITIVE PRECLINICAL DATA IN
VENTILATOR-ASSOCIATED PNEUMONIA WITH ITS NOVEL, PROPRIETARY
HEALIGHT!" DELIVERY TECHNOLOGY
    * AYTU BIOPHARMA INC - PLANS TO REPORT DATA FROM ONGOING,
LARGER
PRECLINICAL STUDY OF HEALIGHT IN VAP LATER IN 2022
    * AYTU - PRECLINICAL PROOF-OF-CONCEPT STUDY DEMONSTRATES
EFFECTIVENESS OF HEALIGHT IN DELAYING TIME TO DEVELOPMENT OF
VENTILATOR-ASSOCIATED PNEUMONIA

Source text: (https://bit.ly/36IiPUM)
Further company coverage:  AYTU.O 

 ((Reuters.Briefs@thomsonreuters.com;))